Compare VanEck Junior Gold Miners (GDXJ) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Junior Gold Miners vs Tempus AI — how do they compare? VanEck Junior Gold Miners trades at $112.8 (market cap $8.22B), while Tempus AI trades at $69.85 (market cap $12.58B). The key difference: Tempus AI is the larger of the two by market cap, and Tempus AI is trading nearer its 52-week high, VanEck Junior Gold Miners nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Junior Gold Miners for 41 Days and Tempus AI for 22 Days on average.
| GDXJ | TEM | |
|---|---|---|
Market Cap | $8.22B | $12.58B |
Volume | 3,212,198 | 7,444,569 |
Sector | Commodities - Metals/Agriculture | Broad Market / Factor |
52-Week High | $156.19 | $99.28 |
52-Week Low | $87.56 | $41.55 |
Typical Hold Time | 41 Days | 22 Days |
Enterprise Value | — | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GDXJ, the VanEck Junior Gold Miners ETF, is trading at $109.14, down 3.88% over the past 24 hours amid a bearish technical signal. The ETF's underlying index recently underwent a semi-annual rebalancing, adding several junior gold mining companies, which may impact its composition and liquidity. Key technical indicators show oversold conditions with RSI readings below 30, while moving averages and the ADX signal a strong downtrend.
The outlook for GDXJ is heavily influenced by gold price movements and the performance of its constituent junior miners. Near-term support lies at $107, with resistance at $110. Risks include gold price volatility, operational challenges at junior mines, and broader market sentiment toward speculative assets. The ETF offers exposure to gold's potential upside but carries higher volatility than senior miner funds.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Junior Gold Miners
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
